Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2778514 | 0.82 | ALDH1A1 (0.69) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| Hydrochloric Acid SCHEMBL23751236 | 0.80 | ALDH1A1 (0.67) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL41372 | 0.80 | ALDH1A1 (0.82) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL63945 | 0.80 | ALDH1A1 (0.67) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL86088 | 0.80 | ALDH1A1 (0.67) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL10702838 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL13564611 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL8788972 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 | |
| SCHEMBL30474466 | 0.77 | CA2 (0.63) | ALDH1A1CA12CA1CA2CA6 | |
| SCHEMBL16537421 | 0.77 | ALDH1A1 (0.69) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118908865-A | Synthesis method of p-toluenesulfonyl methyl isonitrile | 淮北龙溪生物科技有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-100423951-C | Sensitizer dispersion, method for producing same, method for producing mixed dispersion for thermal recording body, and thermal recording body | SANKO CO LTD (JP) | 2008-10-08 | — | — | CN | claimed |
| CN-1795108-A | Method for producing material containing sensitizer dispersed therein for thermal recording article and thermal recording article | SANKO CO LTD (JP) | 2006-06-28 | — | — | CN | claimed |
| WO-2003068204-A1 | SYNTHESIS OF SUBSTITUTED SULFONYL AMINES | Grünenthal GmbH (DE) | 2003-08-21 | — | — | WO | claimed |
| CN-118772161-A | Albumitinib preparation method of intermediate | 山东大学 | 2024-10-15 | — | — | CN | disclosed |
| US-20240239788-A1 | SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240208902-A1 | CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2024-06-27 | — | — | US | disclosed |
| US-20240024346-A1 | CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF | RISEN SUZHOU PHARMA TECH CO LTD (CN) | 2024-01-25 | — | — | US | disclosed |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11802111-B2 | Cyclobutyl amide monoacylglycerol lipase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-31 | — | — | US | disclosed |
| WO-2023187833-A1 | A NOVEL SALT OF BEMPEDOIC ACID | ENALTEC LABS PRIVATE LIMITED (IN) | 2023-10-05 | — | — | WO | disclosed |
| US-11753397-B2 | Cereblon binders for the degradation of ikaros | C4 THERAPEUTICS, INC. (US) | 2023-09-12 | — | — | US | disclosed |
| CN-1646502-A | Triazole derivatives as tachykinin receptor antagonists | LILLY CO ELI (US) | 2005-07-27 | — | — | CN | disclosed |
| EP-1554272-A1 | BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE | ELI LILLY AND COMPANY (US) | 2005-07-20 | — | — | EP | disclosed |
| CN-1185108-C | Thermosensitive recording material | CIBA SC HOLDING AG (CH) | 2005-01-19 | — | — | CN | disclosed |
| WO-2004014900-A1 | BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE | ELI LILLY AND COMPANY (US) | 2004-02-19 | — | — | WO | disclosed |
| WO-2003068204-A1 | SYNTHESIS OF SUBSTITUTED SULFONYL AMINES | Grünenthal GmbH (DE) | 2003-08-21 | — | — | WO | disclosed |
| CN-1330593-A | Heat sensitive recording material | CIBA SC HOLDING AG (CH) | 2002-01-09 | — | — | CN | disclosed |
| US-4132436-A | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1979-01-02 | — | — | US | disclosed |
| US-4119777-A | BY OXIDATION OF A THIOAMIDE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 1978-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | CYP2C19, CYP3A7, CYP3A5 | ALDH1A1 1200/4885CYP3A4 6/4885CYP2C9 5/4885 |
| US-20240024346-A1 | CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF | ENTPD5, NT5E, ENTPD1 | ALDH1A1 425/4885CYP3A4 1184/4885CYP2C9 1046/4885 |
| US-11753397-B2 | Cereblon binders for the degradation of ikaros | CRBN, IKZF1, IKZF3 | ALDH1A1 3363/4885CYP3A4 4129/4885CYP2C9 4731/4885 |
| US-20240239788-A1 | SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT | KRAS, NRAS, HRAS | ALDH1A1 2871/4885CYP3A4 4645/4885CYP2C9 3953/4885 |
| US-20240208902-A1 | CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS | MGLL, LPL, PNLIP | ALDH1A1 472/4885CYP3A4 1069/4885CYP2C9 923/4885 |
| US-11802111-B2 | Cyclobutyl amide monoacylglycerol lipase modulators | MGLL, LPL, PNLIP | ALDH1A1 450/4885CYP3A4 1067/4885CYP2C9 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.